Almonds With/Without Chocolate May Improve Lipid Profiles

Share this content:
Almonds With/Without Chocolate May Improve Lipid Profiles
Almonds With/Without Chocolate May Improve Lipid Profiles

FRIDAY, Dec. 1, 2017 (HealthDay News) -- Eating raw almonds, dark chocolate, and cocoa can significantly improve lipid profiles of overweight and obese people, according to a small study published online Nov. 29 in the Journal of the American Heart Association.

Yujin Lee, Ph.D., from Pennsylvania State University in Hershey, and colleagues assessed the individual and combined effects of consumption of dark chocolate and cocoa and almonds on markers of coronary heart disease risk as part of a feeding trial conducted with 48 overweight and obese individuals aged 30 to 70 years. The four isocaloric, weight maintenance diets included the average American diet, almonds, cocoa powder and dark chocolate, or all three foods (CHOC+ALD).

The researchers found that total cholesterol, non-high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were all lower after the almond diet (P < 0.05), compared with the average American diet. Apolipoprotein B decreased by 5 percent with the CHOC+ALD compared with the average American diet. The almond diet showed a greater drop in large buoyant low-density lipoprotein particles (P = 0.04), whereas the CHOC+ALD had a greater decline in small dense low-density lipoprotein particles (P = 0.04), compared with the average American diet. No significant differences were seen in vascular health and oxidative stress between the diets.

"People are allowed to have about 270 discretionary calories a day, and when foods like almonds, dark chocolate, and cocoa are consumed together as a discretionary food, they confer health benefits unlike other discretionary foods such as frosted donuts," a coauthor said in a statement.

Several authors disclosed financial ties to The Hershey Company and the Almond Board of California, both of which funded the study.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Lab  Companion Tests Perform Similarly for Oncology Analytes

Lab &#43; Companion Tests Perform Similarly for Oncology ...

Findings based on comparison of tests to diagnose oncology-related genetic variants

Ulixertinib Is Active in Patients With Advanced Solid Tumors

Ulixertinib Is Active in Patients With Advanced Solid ...

Responses occurred in patients with NRAS-, BRAF V600-, non-V600 BRAF-mutant solid tumors

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

Doctors Must Report on at Least 1 Patient, ...

To avoid Medicare payment penalty in 2019, clinicians must report by Dec. 31, submit by Feb. 28

is free, fast, and customized just for you!

Already a member?

Sign In Now »